Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02491099
Title A Phase II Evaluation of Afatinibin Patients With Persistent or Recurrent HER2-positive Uterine Serous Carcinoma (Afatinib)
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Yale University
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Arizona Cancer Center COMPLETED Tucson Arizona 85724 United States Details
Yale New Haven Hospital RECRUITING New Haven Connecticut 06510 United States Details
Massachusetts General Hospital COMPLETED Boston Massachusetts 02114 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field